Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
12.60
-0.44 (-3.37%)
Nov 22, 2024, 4:00 PM EST - Market closed

Evolus Revenue

Evolus had revenue of $61.09M in the quarter ending September 30, 2024, with 22.12% growth. This brings the company's revenue in the last twelve months to $248.33M, up 34.43% year-over-year. In the year 2023, Evolus had annual revenue of $202.09M with 35.98% growth.

Revenue (ttm)
$248.33M
Revenue Growth
+34.43%
P/S Ratio
3.07
Revenue / Employee
$909,619
Employees
273
Market Cap
797.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023202.09M53.47M35.98%
Dec 31, 2022148.62M48.94M49.10%
Dec 31, 202199.67M43.13M76.29%
Dec 31, 202056.54M21.62M61.89%
Dec 31, 201934.93M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Services Group 1.70B
Embecta 1.12B
Castle Biosciences 311.88M
Paragon 28 245.00M
Cytek Biosciences 201.21M
Capricor Therapeutics 23.23M
Liquidia 15.61M
Revenue Rankings